BMN 111 in Children with Achondroplasia

• Research type

  Research Study

• Full title

  A Phase 2, Open-label, Sequential Cohort Dose-escalation Study of BMN 111 in Children with Achondroplasia

• IRAS ID

  132144

• Contact name

  Melita Irving

• Contact email

  melita.irving@gstt.nhs.uk

• Sponsor organisation

  BioMarin Pharmaceutical Inc.

• Eudract number

  2013-004137-32

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  East Midlands - Nottingham 2 Research Ethics Committee

• REC reference

  13/EM/0458

• Date of REC Opinion

  3 Apr 2014

• REC opinion

  Further Information Favourable Opinion